These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24847127)

  • 1. It's time to study cardiac magnetic resonance imaging as a strategic tool in nonischemic cardiomyopathy.
    Ghosh N; Kwong RY
    Circ Heart Fail; 2014 May; 7(3):391-3. PubMed ID: 24847127
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of Cardiac MR Imaging in Cardiomyopathies.
    Kramer CM
    J Nucl Med; 2015 Jun; 56 Suppl 4(0 4):39S-45S. PubMed ID: 26033902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies.
    Shehata ML; Turkbey EB; Vogel-Claussen J; Bluemke DA
    Top Magn Reson Imaging; 2008 Feb; 19(1):43-57. PubMed ID: 18690160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cardiac MRI in nonischemic cardiomyopathies.
    Anand S; Janardhanan R
    Indian Heart J; 2016; 68(3):405-9. PubMed ID: 27316506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of non-invasive imaging in the work-up of cardiomyopathies.
    Tummala LS; Young RK; Singh T; Jani S; Srichai MB
    Curr Atheroscler Rep; 2015 Mar; 17(3):486. PubMed ID: 25637041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure.
    Masci PG; Doulaptsis C; Bertella E; Del Torto A; Symons R; Pontone G; Barison A; Droogné W; Andreini D; Lorenzoni V; Gripari P; Mushtaq S; Emdin M; Bogaert J; Lombardi M
    Circ Heart Fail; 2014 May; 7(3):448-56. PubMed ID: 24647118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between extent of myocardial fibrosis assessed by cardiac magnetic resonance and cardiac troponin T release in patients with nonischemic heart failure.
    Takashio S; Yamamuro M; Uemura T; Utsunomiya D; Morita K; Izumiya Y; Sugiyama S; Kojima S; Yamamoto E; Tsujita K; Tanaka T; Tayama S; Kaikita K; Hokimoto S; Yasuda O; Yamashita Y; Ogawa H
    Am J Cardiol; 2014 May; 113(10):1697-704. PubMed ID: 24698466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myocardium non-compaction].
    Stukalova OV; Shiriaev GA; Harusov ON; Ternovoĭ SK
    Kardiologiia; 2012; 52(9):94-6. PubMed ID: 23098553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary hemochromatosis with cardiac involvement].
    Mel'nik SG; Polushin OG
    Arkh Patol; 1990; 52(1):66-8. PubMed ID: 2140039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of Cardiac Magnetic Resonance Imaging in Patients With Failed Ablation Procedures for Ventricular Tachycardia.
    Njeim M; Yokokawa M; Frank L; Crawford T; Good E; Morady F; Bogun F
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):183-9. PubMed ID: 26445386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congestive cardiomyopathy in Doberman pinscher dogs.
    Calvert CA; Chapman WL; Toal RL
    J Am Vet Med Assoc; 1982 Sep; 181(6):598-602. PubMed ID: 7141953
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.
    Yoshida A; Ishibashi-Ueda H; Yamada N; Kanzaki H; Hasegawa T; Takahama H; Amaki M; Asakura M; Kitakaze M
    Eur J Heart Fail; 2013 Feb; 15(2):166-75. PubMed ID: 23329703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.
    Iles L; Pfluger H; Lefkovits L; Butler MJ; Kistler PM; Kaye DM; Taylor AJ
    J Am Coll Cardiol; 2011 Feb; 57(7):821-8. PubMed ID: 21310318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of Myocardial Contrast-Enhanced T
    Höke U; Khidir MJ; van der Geest RJ; Schalij MJ; Bax JJ; Delgado V; Ajmone Marsan N
    Am J Cardiol; 2017 May; 119(9):1456-1462. PubMed ID: 28274575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of cardiac magnetic resonance imaging and myocardial biopsy in the evaluation of nonischemic cardiomyopathy.
    Dickerson JA; Raman SV; Baker PM; Leier CV
    Congest Heart Fail; 2013; 19(1):29-38. PubMed ID: 22963032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial calcification after orthotopic heart transplantation.
    Lin A; Greaves S; Kingston N; Milne D; Ruygrok P
    J Heart Lung Transplant; 2014 Feb; 33(2):219-21. PubMed ID: 24315786
    [No Abstract]   [Full Text] [Related]  

  • 17. Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: current applications and future perspectives.
    Gottlieb I; Macedo R; Bluemke DA; Lima JA
    Heart Fail Rev; 2006 Dec; 11(4):313-23. PubMed ID: 17131077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy.
    Greene SJ; Epstein SE; Kim RJ; Quyyumi AA; Cole RT; Anderson AS; Wilcox JE; Skopicki HA; Sikora S; Verkh L; Tankovich NI; Gheorghiade M; Butler J
    J Cardiovasc Med (Hagerstown); 2017 Apr; 18(4):283-290. PubMed ID: 26479144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [71-year-old patient with cardiac decompensation and cardiomegaly. Unexpected diagnostic change].
    Altmann C; Staubach P; Sack R
    Internist (Berl); 1994 Jun; 35(6):564-7. PubMed ID: 8071029
    [No Abstract]   [Full Text] [Related]  

  • 20. A few more pieces in the puzzle of non-compaction cardiomyopathy.
    Willemsen HM; van den Berg MP
    Eur J Heart Fail; 2011 Feb; 13(2):127-9. PubMed ID: 21262927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.